Cargando…

An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

The drug fenofibrate has received major attention as a novel medical treatment for diabetic retinopathy (DR) and other diabetes-induced microvascular complications. This interest stems from two recent large, well-designed clinical trials that demonstrated large reductions in the progression of DR an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noonan, Jonathan E., Jenkins, Alicia J., Ma, Jian-Xing, Keech, Anthony C., Wang, Jie Jin, Lamoureux, Ecosse L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837039/ https://www.ncbi.nlm.nih.gov/pubmed/24264394 http://dx.doi.org/10.2337/db13-0800

Ejemplares similares

Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol
por: Su, Xing-jie, et al.
Publicado: (2019)

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients
por: Ju, Hai-Bing, et al.
Publicado: (2017)

Diabetic Retinopathy in 2011: Further Insights From New Epidemiological Studies and Clinical Trials
por: Lamoureux, Ecosse L., et al.
Publicado: (2011)

Should We Start All Patients with Diabetic Retinopathy on Fenofibrates?
por: Koshy, Jacob, et al.
Publicado: (2013)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013)

Reverse Translational Study of Fenofibrate's Observed Effects in Diabetes‐Associated Retinopathy
por: Farris, RA, et al.
Publicado: (2016)

Language barrier and its relationship to diabetes and diabetic retinopathy
por: Zheng, Yingfeng, et al.
Publicado: (2012)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
por: Scott, Russell, et al.
Publicado: (2009)

Microvascular retinopathy and angiographically-demonstrated coronary artery disease: A cross-sectional, observational study
por: Cheng, Lisa, et al.
Publicado: (2018)

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study
por: Ting, Ru-Dee, et al.
Publicado: (2012)

Short-term poor glycemic control and retinal microvascular changes in pediatric Type 1 Diabetes patients in Singapore: a pilot study
por: Li, Ling-Jun, et al.
Publicado: (2017)

Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)

Validation of a New Diabetic Retinopathy Knowledge and Attitudes Questionnaire in People with Diabetic Retinopathy and Diabetic Macular Edema
por: Fenwick, Eva K., et al.
Publicado: (2020)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
por: Januszewski, Andrzej S., et al.
Publicado: (2021)

Problem-solving therapy for adults with diabetic retinopathy and diabetes-specific distress: a pilot randomized controlled trial
por: Rees, Gwyneth, et al.
Publicado: (2017)

Dietary intake and diabetic retinopathy: A systematic review
por: Wong, Mark Y. Z., et al.
Publicado: (2018)

Linguistic and Cultural Validation of the Diabetic Retinopathy Knowledge and Attitudes Scale (DRKA) in a Chinese Population
por: Jiang, Weiwei, et al.
Publicado: (2023)

Diabetic retinopathy: An update
por: Singh, Ramandeep, et al.
Publicado: (2008)

Shared Care for Patients with Diabetes at Risk of Retinopathy: A Feasibility Trial
por: Mathur, Ranjana, et al.
Publicado: (2019)

Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan
por: Lin, Ying-Chieh, et al.
Publicado: (2020)

The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study
por: Ong, Kwok-Leung, et al.
Publicado: (2021)

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
por: Farnier, Michel
Publicado: (2008)

Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone
por: Fenwick, Eva K., et al.
Publicado: (2017)

Mitochondrial haplogroups are not associated with diabetic retinopathy in a large Australian and British Caucasian sample
por: Liu, Ebony, et al.
Publicado: (2019)

Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
por: Wong, Chee Wai, et al.
Publicado: (2015)

The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes
por: Chua, Jacqueline, et al.
Publicado: (2018)

Update on genetics and diabetic retinopathy
por: Hampton, Blake M, et al.
Publicado: (2015)

Update on the Treatment of Diabetic Retinopathy
por: Wilkinson-Berka, Jennifer L., et al.
Publicado: (2008)

Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy
por: Fu, Dongxu, et al.
Publicado: (2020)

Optical coherence tomography angiography microvascular changes in diabetics without diabetic retinopathy
por: Lajmi, Houda, et al.
Publicado: (2021)

Relationship between diabetic retinopathy and diabetic peripheral neuropathy - Neurodegenerative and microvascular changes
por: Rasheed, Rehna, et al.
Publicado: (2021)

Computerized Adaptive Tests: Efficient and Precise Assessment of the Patient-Centered Impact of Diabetic Retinopathy
por: Fenwick, Eva K., et al.
Publicado: (2020)

Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease
por: Miller, David J., et al.
Publicado: (2020)

Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies
por: Rodríguez, María L., et al.
Publicado: (2019)

Predictive factors for microvascular recovery after treatments for diabetic retinopathy
por: Lee, Junyeop, et al.
Publicado: (2023)

Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
por: Goldney, Jonathan, et al.
Publicado: (2023)

Updates on Gene Therapy for Diabetic Retinopathy
por: Wang, Jiang-Hui, et al.
Publicado: (2020)

Associations with sight-threatening diabetic macular oedema among Indigenous adults with type 2 diabetes attending an Indigenous primary care clinic in remote Australia: a Centre of Research Excellence in Diabetic Retinopathy and Telehealth Eye and Associated Medical Services Network study
por: Brazionis, Laima, et al.
Publicado: (2021)

Factors Associated with Knowledge of Diabetes in Patients with Type 2 Diabetes Using the Diabetes Knowledge Test Validated with Rasch Analysis
por: Fenwick, Eva K., et al.
Publicado: (2013)

Ocular Associations of Diabetes Other Than Diabetic Retinopathy
por: Jeganathan, V. Swetha E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gm481r70mn2qs9i19s36jnkvki